The global pyrogen testing market is growing at a significant rate, due to speedy growth in pharmaceutical and biotechnology industries and the mounting number of novel drug launches. Different products contributed to the pyrogen testing market size.

Request for a sample copy of this research report at https://www.vynzresearch.com/healthcare/pyrogen-testing-market/request-sample

Alter from animal-based testing to in vitro testing are the trends in the pyrogen testing market. Speedy growth in pharmaceutical and biotechnology industries, robust R&D investments in the life sciences industry, the mounting number of novel drug launches, and mounting government support for pharmaceutical and biotechnology industries are the primary growth drivers for pyrogen testing market.

Mounting pharmaceutical outsourcing and substantial opportunities for the pyrogen testing market in developing economies are also facilitating the growth for the pyrogen testing market. High degree of consolidation is the major challenges for the growth of pyrogen testing market.

North America is the largest pyrogen testing market as in the region the investment by government in healthcare and pharmaceutical industry is increasing.

Asia-Pacific is observed to witness the fastest growth in the market, due to mounting research and development of novel drugs.

Key players in the pyrogen testing market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe.

Associates of Cape Cod, Inc., Merck KGaA, Thermo Fisher Scientific, Inc., GenScript, Charles River Laboratories, Inc., Ellab A/S, Lonza Group, and WUXI Pharmatech (Cayman) Inc. are the key players offering pyrogen testing.

Source: VynZ Research